Parkway Life REIT Exits a Mature Japan Nursing Home for S$9.4M — 38% Above Its 2008 Cost and 5% Over Valuation, Sold Straight to the Sitting Operator

Parkway Life REIT has completed the divestment of Etoile Suma Rikyu, a nursing home in Hyogo Prefecture, Japan, for JPY1,165.5 million — approximately S$9.4 million. The price is about 38% above the property’s 2008 purchase cost and 5% above its latest independent valuation, crystallising an estimated gain on disposal of around S$0.6 million before tax. Completion and cash settlement both took place on 30 June 2026.

Parkway Life REIT (PLife REIT, SGX:C2PU) is one of Asia’s largest listed healthcare REITs, with a portfolio of 74 properties worth around S$2.6 billion as at 31 December 2025 — the largest private-hospital portfolio in Singapore (Mount Elizabeth, Gleneagles and Parkway East), 60 nursing and care-facility assets across Japan, and 11 assets in France. Japan contributes roughly a quarter of total portfolio revenue, so a single nursing home is, by design, a small line.

A sale to the sitting operator

The most useful detail is the counterparty. The buyer, K.K. Etoile, is the property’s existing operator and a subsidiary of the Yoshimei Group, an established Japanese corporate group with annual sales exceeding JPY35 billion in FY2025. A direct, off-market sale to the tenant-operator removes marketing and vacant-possession risk and, as the Manager frames it, delivers a high degree of execution certainty and an orderly exit. It is also a data point on who is buying mature Japanese care assets, and at what level: the consideration came in 5.0% above the JPY1,110 million valuation set by independent valuer ENRIX as at 31 December 2025.

The premium is real, but the annualised return is modest

The headline — a 38% premium to the JPY844 million paid in 2008 — sounds emphatic, but over an roughly 18-year hold it works out to only about 1.8% a year in yen terms. A note of caution on the Singapore-dollar figures: the announcement converts both the 2008 cost and the 2026 sale at a single current rate of S$1.00:JPY124.38, so the S$6.8 million “cost” and S$9.4 million “sale” do not capture the yen’s substantial depreciation against the Singapore dollar over the holding period. The real story is not capital appreciation. It is a mature asset, with rising future capital-expenditure needs, exited at an attractive valuation — with the roughly S$9.2 million of net proceeds (after about S$0.2 million of fees and expenses) earmarked for redeployment into higher-growth opportunities.

The read

This is portfolio housekeeping of the cleanest kind — a Non-Discloseable transaction with no material impact on distribution per unit or net tangible assets for the financial year ending 31 December 2026, executed at a premium to valuation and sold to the party that knows the asset best. It will not move the units, and it is not meant to. It fits a pattern visible across the S-REIT space this quarter: managers trimming mature, capex-heavy assets near valuation and recycling the proceeds, where the win is de-risking and balance-sheet flexibility rather than a headline gain. The thing to watch is redeployment — whether PLife REIT’s stated intent to pursue higher-growth opportunities turns into an actual acquisition.

Source: Parkway Life REIT SGXNet announcement and accompanying news release, “Divestment of a Nursing Home Property Located in Japan,” dated 30 June 2026. Currency conversions at the Manager’s stated rate of S$1.00:JPY124.38. PropertyAtlas.sg analysis with TKRE Research.